Literature DB >> 22644166

Peripheral neuromodulation in chronic migraine.

F Perini1, A De Boni.   

Abstract

Patients with chronic migraines are often refractory to medical treatment. Therefore, they might need other strategies to modulate their pain, according to their level of disability. Neuromodulation can be achieved with several tools: meditation, biofeedback, physical therapy, drugs and electric neurostimulation (ENS). ENS can be applied to the central nervous system (brain and spinal cord), either invasively (cortical or deep brain) or non-invasively [cranial electrotherapy stimulation, transcranial direct current stimulation and transcranial magnetic stimulation]. Among chronic primary headaches, cluster headaches are most often treated either through deep brain stimulation or occipital nerve stimulation because there is a high level of disability related to this condition. ENS, employed through several modalities such as transcutaneous electrical nerve stimulation, interferential currents and pulsed radiofrequency, has been applied to the peripheral nervous system at several sites. We briefly review the indications for the use of peripheral ENS at the site of the occipital nerves for the treatment of chronic migraine.

Entities:  

Mesh:

Year:  2012        PMID: 22644166     DOI: 10.1007/s10072-012-1039-4

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  15 in total

1.  Observations on electrical stimulation of pain fibres in an exposed human sensory nerve.

Authors:  R E PATTLE; G WEDDELL
Journal:  J Neurophysiol       Date:  1948-03       Impact factor: 2.714

Review 2.  Neurostimulation for primary headache disorders, part 1: pathophysiology and anatomy, history of neuromodulation in headache treatment, and review of peripheral neuromodulation in primary headaches.

Authors:  Brian Jenkins; Stewart J Tepper
Journal:  Headache       Date:  2011-08-04       Impact factor: 5.887

Review 3.  Disability in chronic daily headache: state of the art and future directions.

Authors:  Domenico D'Amico; L Grazzi; S Usai; A Raggi; M Leonardi; G Bussone
Journal:  Neurol Sci       Date:  2011-05       Impact factor: 3.307

Review 4.  Defining the pharmacologically intractable headache for clinical trials and clinical practice.

Authors:  Stephen D Silberstein; David W Dodick; Starr Pearlman
Journal:  Headache       Date:  2010-10       Impact factor: 5.887

5.  Defining refractory migraine and refractory chronic migraine: proposed criteria from the Refractory Headache Special Interest Section of the American Headache Society.

Authors:  Elliott A Schulman; Alvin E Lake; Peter J Goadsby; B Lee Peterlin; Sherry E Siegel; Herbert G Markley; Richard B Lipton
Journal:  Headache       Date:  2008-05-14       Impact factor: 5.887

6.  Defining refractory migraine: results of the RHSIS Survey of American Headache Society members.

Authors:  Elliott A Schulman; B Lee Peterlin; Alvin E Lake; Richard B Lipton; Alexandra Hanlon; Sherry Siegel; Morris Levin; Peter J Goadsby; Herbert G Markley
Journal:  Headache       Date:  2009-02-25       Impact factor: 5.887

7.  Peripheral neurostimulation for the treatment of chronic, disabling transformed migraine.

Authors:  Charles A Popeney; Kenneth M Aló
Journal:  Headache       Date:  2003-04       Impact factor: 5.887

8.  Greater occipital nerve stimulation via the Bion microstimulator: implantation technique and stimulation parameters. Clinical trial: NCT00205894.

Authors:  Terrence L Trentman; David M Rosenfeld; Bert B Vargas; Todd J Schwedt; Richard S Zimmerman; David W Dodick
Journal:  Pain Physician       Date:  2009 May-Jun       Impact factor: 4.965

9.  Occipital nerve stimulation for the treatment of intractable chronic migraine headache: ONSTIM feasibility study.

Authors:  Joel R Saper; David W Dodick; Stephen D Silberstein; Sally McCarville; Mark Sun; Peter J Goadsby
Journal:  Cephalalgia       Date:  2010-09-22       Impact factor: 6.292

10.  Refractory migraine in a headache clinic population.

Authors:  Pablo Irimia; Jose-Alberto Palma; Roberto Fernandez-Torron; Eduardo Martinez-Vila
Journal:  BMC Neurol       Date:  2011-08-01       Impact factor: 2.474

View more
  3 in total

1.  A reanalysis of a randomized trial on meditation for migraine headaches: Distraction is not enough but meditation takes time.

Authors:  Amy Wachholtz; Rini Vohra; Aaron Metzger
Journal:  Complement Ther Med       Date:  2019-08-14       Impact factor: 2.446

2.  Efficacy of Pulsed Radiofrequency on Cervical 2-3 Posterior Medial Branches in Treating Chronic Migraine: A Randomized, Controlled, and Double-Blind Trial.

Authors:  Yuecheng Yang; Xuehua Huang; Yinghui Fan; Yingwei Wang; Ke Ma
Journal:  Evid Based Complement Alternat Med       Date:  2015-06-11       Impact factor: 2.629

3.  Neuromodulation for cephalgias.

Authors:  Serge Y Rasskazoff; Konstantin V Slavin
Journal:  Surg Neurol Int       Date:  2013-04-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.